Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 April 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 5MB, 226 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website

 

 

Export 289 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is C  [Clear All Filters]
2012
A. Bakhai, Rigney, U., Hollis, S., and Emmas, C., Co-administration of statins with cytochrome P450 3A4 inhibitors in a UK primary care population, Pharmacoepidemiol Drug Saf, vol. 21, pp. 485-93, 2012.
N. Bhattarai, Charlton, J., Rudisill, C., and Gulliford, M. C., Coding, recording and incidence of different forms of coronary heart disease in primary care, PLoS One, vol. 7, p. e29776, 2012.
R. Charlton, Snowball, J., Bloomfield, K., and de Vries, C., Colorectal cancer incidence on the General Practice Research Database, Pharmacoepidemiol Drug Saf, vol. 21, pp. 775-783, 2012.
N. M. Hawkins, Scholes, S., Bajekal, M., Love, H., O'Flaherty, M., Raine, R., and Capewell, S., Community care in England: reducing socioeconomic inequalities in heart failure, Circulation, vol. 126, pp. 1050-7, 2012.
H. Li, Hodgson, E., Watson, L., Shukla, A., and Nelson, J. J., Comorbidities and Concomitant Medication Use in Men with Prostate Cancer or High Levels of PSA Compared to Matched Controls: A GPRD Analysis, J Cancer Epidemiol, vol. 2012, p. 291704, 2012.
D. C. Perry, Bruce, C. E., Pope, D., Dangerfield, P., Platt, M. J., and Hall, A. J., Comorbidities in Perthes' disease: a case control study using the General Practice Research database, J Bone Joint Surg Br, vol. 94, pp. 1684-9, 2012.
H. Jick, Wilson, A., Wiggins, P., and Chamberlain, D. P., Comparison of prescription drug costs in the United States and the United Kingdom, part 2: proton pump inhibitors, Pharmacotherapy, vol. 32, pp. 489-92, 2012.
M. C. Kulik, Nusselder, W. J., Boshuizen, H. C., Lhachimi, S. K., Fernandez, E., Baili, P., Bennett, K., Mackenbach, J. P., and Smit, H. A., Comparison of tobacco control scenarios: quantifying estimates of long-term health impact using the DYNAMO-HIA modeling tool, PLoS One, vol. 7, p. e32363, 2012.
R. Boggon, Eaton, S., Timmis, A., Hemingway, H., Gabriel, H., Minhas, I., and van Staa, T. P., Current prescribing of statins and persistence to statins following ACS in the UK: a MINAP/GPRD study, Br J Cardiol, vol. 19, p. 24, 2012.
2011
D. Prieto-Alhambra, Javaid, M. K., Maskell, J., Judge, A., Nevitt, M., Cooper, C., and Arden, N. K., Changes in hip fracture rate before and after total knee replacement due to osteoarthritis: a population-based cohort study, Ann Rheum Dis, vol. 70, pp. 134-8, 2011.
R. Boggon, van Staa, T. P., Timmis, A., Hemingway, H., Ray, K. K., Begg, A., Emmas, C., and Fox, K. A., Clopidogrel discontinuation after acute coronary syndromes: frequency, predictors and associations with death and myocardial infarction–a hospital registry-primary care linked cohort (MINAP-GPRD), Eur Heart J, vol. 32, pp. 2376-86, 2011.
M. C. Gulliford, Van Staa, T., McDermott, L., Dregan, A., McCann, G., Ashworth, M., Charlton, J., Grieve, A. P., Little, P., Moore, M. V., and Yardley, L., Cluster randomised trial in the General Practice Research Database: 1. Electronic decision support to reduce antibiotic prescribing in primary care (eCRT study), Trials, vol. 12, p. 115, 2011.
R. A. Charlton, Weil, J. G., Cunnington, M. C., Ray, S., and de Vries, C. S., Comparing the General Practice Research Database and the UK Epilepsy and Pregnancy Register as tools for postmarketing teratogen surveillance: anticonvulsants and the risk of major congenital malformations, Drug Saf, vol. 34, pp. 157-71, 2011.
T. P. van Staa, Setakis, E., Di Tanna, G. L., Lane, D. A., and Lip, G. Y., A comparison of risk stratification schemes for stroke in 79,884 atrial fibrillation patients in general practice, J Thromb Haemost, vol. 9, pp. 39-48, 2011.
L. Parkin, Hagberg, K. W., and Jick, H., Comprehensive comparison of drug prescribing in the United States and United Kingdom, Pharmacotherapy, vol. 31, pp. 623-9, 2011.
D. J. Humes, Fleming, K. M., Spiller, R. C., and West, J., Concurrent drug use and the risk of perforated colonic diverticular disease: a population-based case-control study, Gut, vol. 60, pp. 219-24, 2011.
L. Azoulay, Dell'Aniello, S., Huiart, L., Fort, G. G. du, and Suissa, S., Concurrent use of tamoxifen with CYP2D6 inhibitors and the risk of breast cancer recurrence, Breast Cancer Res Treat, vol. 126, pp. 695-703, 2011.
2010
C. Becker, Brobert, G. P., Johansson, S., Jick, S. S., and Meier, C. R., Cancer risk in association with Parkinson disease: a population-based study, Parkinsonism Relat Disord, vol. 16, pp. 186-90, 2010.
K. Abuabara, Azfar, R. S., Shin, D. B., Neimann, A. L., Troxel, A. B., and Gelfand, J. M., Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K, Br J Dermatol, vol. 163, pp. 586-92, 2010.
C. Schneider, Bothner, U., Jick, S. S., and Meier, C. R., Chronic obstructive pulmonary disease and the risk of cardiovascular diseases, Eur J Epidemiol, vol. 25, pp. 253-60, 2010.
L. Azoulay, Schneider-Lindner, V., Dell'Aniello, S., Schiffrin, A., and Suissa, S., Combination therapy with sulfonylureas and metformin and the prevention of death in type 2 diabetes: a nested case-control study, Pharmacoepidemiol Drug Saf, vol. 19, pp. 335-42, 2010.
F. de Vries, Setakis, E., and van Staa, T. P., Concomitant use of ibuprofen and paracetamol and the risk of major clinical safety outcomes, Br J Clin Pharmacol, vol. 70, pp. 429-38, 2010.
N. F. Khan, Ward, A. M., Watson, E., and Rose, P. W., Consulting and prescribing behaviour for anxiety and depression in long-term survivors of cancer in the UK, Eur J Cancer, vol. 46, pp. 3339-44, 2010.
C. Schneider, Jick, S. S., Bothner, U., and Meier, C. R., COPD and the risk of depression, Chest, vol. 137, pp. 341-7, 2010.
2009
I. C. Wong, Asherson, P., Bilbow, A., Clifford, S., Coghill, D., DeSoysa, R., Hollis, C., McCarthy, S., Murray, M., Planner, C., Potts, L., Sayal, K., and Taylor, E., Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)–a pharmacoepidemiological and qualitative study, Health Technol Assess, vol. 13, pp. iii-iv, ix-xi, 1-120, 2009.
R. Ackers, Besag, F. M., Wade, A., Murray, M. L., and Wong, I. C., Changing trends in antiepileptic drug prescribing in girls of child-bearing potential, Arch Dis Child, vol. 94, pp. 443-7, 2009.
A. Ruigomez, Masso-Gonzalez, E. L., Johansson, S., Wallander, M. A., and Garcia-Rodriguez, L. A., Chest pain without established ischaemic heart disease in primary care patients: associated comorbidities and mortality, Br J Gen Pract, vol. 59, pp. e78-86, 2009.
L. A. Garcia Rodriguez, Wallander, M. A., Tolosa, L. B., and Johansson, S., Chronic obstructive pulmonary disease in UK primary care: incidence and risk factors, Copd, vol. 6, pp. 369-79, 2009.
M. O. Bernier, Mikaeloff, Y., Hudson, M., and Suissa, S., Combined oral contraceptive use and the risk of systemic lupus erythematosus, Arthritis Rheum, vol. 61, pp. 476-81, 2009.
M. A. Feudjo-Tepie, Le Roux, G., Beach, K. J., Bennett, D., and Robinson, N. J., Comorbidities of idiopathic thrombocytopenic purpura: a population-based study, Adv Hematol, vol. 2009, p. 963506, 2009.
T. P. van Staa, Leufkens, H. G., Zhang, B., and Smeeth, L., A comparison of cost effectiveness using data from randomized trials or actual clinical practice: selective cox-2 inhibitors as an example, PLoS Med, vol. 6, p. e1000194, 2009.
R. De Natale, Lafuma, A., and Berdeaux, G., Cost effectiveness of travoprost versus a fixed combination of latanoprost/timolol in patients with ocular hypertension or glaucoma: analysis based on the UK general practitioner research database, Clin Drug Investig, vol. 29, pp. 111-20, 2009.
2008
E. Setakis, Leufkens, H. G., and van Staa, T. P., Changes in the characteristics of patients prescribed selective cyclooxygenase 2 inhibitors after the 2004 withdrawal of rofecoxib, Arthritis Rheum, vol. 59, pp. 1105-11, 2008.
S. Rietbrock, Heeley, E., Plumb, J., and Van Staa, T., Chronic atrial fibrillation: Incidence, prevalence, and prediction of stroke using the Congestive heart failure, Hypertension, Age >75, Diabetes mellitus, and prior Stroke or transient ischemic attack (CHADS2) risk stratification scheme, Am Heart J, vol. 156, pp. 57-64, 2008.
Y. X. Yang, Hennessy, S., Propert, K., Hwang, W. T., Sarkar, M., and Lewis, J. D., Chronic statin therapy and the risk of colorectal cancer, Pharmacoepidemiol Drug Saf, vol. 17, pp. 869-76, 2008.
J. Griffin, Lee, S., Caiado, M., Kesten, S., and Price, D., Comparison of tiotropium bromide and combined ipratropium/salbutamol for the treatment of COPD: a UK General Practice Research Database 12-month follow-up study, Prim Care Respir J, vol. 17, pp. 104-10, 2008.
P. Denis, Lafuma, A., and Berdeaux, G., Costs and persistence of alpha-2 adrenergic agonists versus carbonic anhydrase inhibitors, both associated with prostaglandin analogues, for glaucoma as recorded by The United Kingdom General Practitioner Research Database, Clin Ophthalmol, vol. 2, pp. 321-9, 2008.
A. Lafuma, Laurendeau, C., and Berdeaux, G., Costs and persistence of brimonidine versus brinzolamide in everyday glaucoma care: an analysis conducted on the UK General Practitioner Research Database, J Med Econ, vol. 11, pp. 485-97, 2008.
A. Lafuma and Berdeaux, G., Costs and persistence of carbonic anhydrase inhibitor versus alpha-2 agonists, associated with beta-blockers, in glaucoma and ocular hypertension: an analysis of the UK-GPRD database, Curr Med Res Opin, vol. 24, pp. 1519-27, 2008.
2006
S. Hernandez-Diaz and Rodriguez, L. A. Garcia, Cardioprotective aspirin users and their excess risk of upper gastrointestinal complications, BMC Med, vol. 4, p. 22, 2006.
A. Ruigomez, Rodriguez, L. A., Wallander, M. A., Johansson, S., and Jones, R., Chest pain in general practice: incidence, comorbidity and mortality, Fam Pract, vol. 23, pp. 167-74, 2006.
J. M. Burnham, Shults, J., Weinstein, R., Lewis, J. D., and Leonard, M. B., Childhood onset arthritis is associated with an increased risk of fracture: a population based study using the General Practice Research Database, Ann Rheum Dis, vol. 65, pp. 1074-9, 2006.
T. P. van Staa, Geusens, P., Bijlsma, J. W., Leufkens, H. G., and Cooper, C., Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis, Arthritis Rheum, vol. 54, pp. 3104-12, 2006.
A. Ruigomez, Rodriguez, L. A. Garcia, Wallander, M. A., Johansson, S., and Dent, J., Comparison of gastro-oesophageal reflux disease and heartburn diagnoses in UK primary care, Curr Med Res Opin, vol. 22, pp. 1661-8, 2006.
I. Williamson, Benge, S., Mullee, M., and Little, P., Consultations for middle ear disease, antibiotic prescribing and risk factors for reattendance: a case-linked cohort study, Br J Gen Pract, vol. 56, pp. 170-5, 2006.
F. Andersohn, Schade, R., Suissa, S., and Garbe, E., Cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs and the risk of ischemic stroke: a nested case-control study, Stroke, vol. 37, pp. 1725-30, 2006.
[Page last reviewed 6 April 2021]